MedPath

Remaxazon External Patch

REMAXAZON EXTERNAL PATCH

Approved
Approval ID

10e0247a-5ffd-064e-e054-00144ff8d46c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 9, 2015

Manufacturers
FDA

Home Aide Diagnostics, Inc.

DUNS: 783518983

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Remaxazon External Patch

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69379-285
Product Classification
G
Generic Name
Remaxazon External Patch
Product Specifications
Route of AdministrationTOPICAL
Effective DateMarch 9, 2015
FDA Product Classification

INGREDIENTS (4)

CHONDROITIN SULFATE SODIUM (BOVINE)Active
Quantity: 3 g in 100 g
Code: 8QTV3DTT8W
Classification: ACTIM
GLUCOSAMINEActive
Quantity: 5 g in 100 g
Code: N08U5BOQ1K
Classification: ACTIB
CAPSAICINActive
Quantity: .0285 g in 100 g
Code: S07O44R1ZM
Classification: ACTIB
LIDOCAINEActive
Quantity: 4 g in 100 g
Code: 98PI200987
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Remaxazon External Patch - FDA Drug Approval Details